KALA BIO, Inc. KALA
0.48
(0.08)
(14.29%)
as of 25 Sep
- Market cap
- $10.7M
- P/E
- 0.0×
Follow KALA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/S ratio |
— | — | — | 20.81 | 55.95 | 7.08 | 8.45 | — | — | — |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/Operating CF |
— | — | — | (6.94) | (13.73) | (2.85) | (3.54) | — | — | — |
P/B ratio |
— | — | — | 4.26 | 3.56 | 4.73 | 2.56 | — | — | — |
Price to Tangible BV |
— | — | — | 4.26 | 3.56 | 4.73 | 2.56 | — | — | — |
EV/Sales |
— | — | — | 18.68 | 43.41 | 7.19 | 5.21 | — | — | — |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
— | — | — | (1.22) | (3.05) | (0.75) | (0.38) | — | — | — |
EV/FCF |
— | — | — | (1.21) | (2.98) | (0.74) | (0.38) | — | — | — |
Quick Ratio |
8.20 | 7.70 | 10.11 | 3.92 | 7.34 | 2.93 | 2.75 | 6.10 | 3.02 | 3.03 |
Current Ratio |
8.23 | 7.75 | 10.41 | 4.26 | 7.71 | 3.32 | 3.35 | 6.33 | 3.11 | 3.81 |
Net Debt/EBITDA |
1.11 | 2.45 | 1.56 | 0.15 | 0.85 | (0.01) | 0.23 | 0.33 | 0.41 | 0.19 |
Debt/Assets |
20.84% | 16.01% | 31.99% | 46.99% | 33.29% | 68.48% | 59.78% | 68.46% | 63.26% | 0.00% |
Debt/Equity |
0.32 | 0.21 | 0.67 | 2.44 | 0.74 | 5.68 | 2.74 | 5.10 | 2.85 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.06 | 0.03 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.82 | 0.81 | 0.81 | 0.98 | 0.87 | 0.76 | 1.76 | 0.66 | 0.76 | 1.19 |
Capex/Depreciation |
(0.38) | (0.64) | (2.52) | (0.74) | (0.99) | (0.32) | (0.10) | (0.36) | (0.14) | 0.04 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (3,460.30%) | (4,403.86%) | (68.57%) | (140.12%) | (160.89%) | (244.19%) | (250.56%) | (318.75%) | (388.29%) | (279.19%) | |
| (143.18%) | (51.83%) | (39.55%) | (50.28%) | (55.50%) | (79.00%) | (39.62%) | (59.12%) | (69.12%) | (83.05%) | |
ROIC |
0.00% | 0.00% | (848.20%) | (329.12%) | (297.33%) | (449.62%) | (13,403.22%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(81.54%) | (41.74%) | (41.15%) | (113.12%) | (68.49%) | (159.04%) | (73.89%) | (93.20%) | (105.25%) | (385.65%) |
Average Days of Receivables |
— | — | 0.00 | 694.85 | 551.00 | 498.30 | 18.29 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 449.05% | 288.46% | 102.45% | 453.57% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 1,070.38% | 1,274.25% | 934.71% | 1,670.99% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 164.49% | 209.24% | 143.13% | 180.06% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | (0.15) | 0.14 | 0.02 | 0.37 | — | — | — |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
— | — | — | (74.80%) | (29.65%) | (179.34%) | (94.15%) | — | — | — |
Free Cash Flow Yield |
— | — | — | (74.42%) | (26.03%) | (137.04%) | (162.89%) | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 443.36 | 302.95 | 427.38 | 128.03 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(54,696.00) | (7,412.61) | (5,058.04) | (6,767.88) | (4,318.76) | (4,115.40) | (2,595.66) | (574.63) | (387.11) | (196.26) |
Capex per Share |
(306.00) | (104.35) | (147.48) | (97.45) | (92.48) | (30.19) | (6.55) | (11.58) | (2.74) | (0.09) |
Free Cash Flow per Share |
(55,002.00) | (7,516.96) | (5,205.51) | (6,865.33) | (4,411.24) | (4,145.59) | (2,602.20) | (586.21) | (389.86) | (196.36) |
Cash per Share |
90,944.00 | 24,905.43 | 15,971.78 | 6,237.15 | 7,311.43 | 3,580.91 | 2,318.91 | 1,047.22 | 674.32 | 46.36 |
Shareholders Equity per Share |
61,258.00 | 19,495.43 | 9,811.03 | 2,167.30 | 4,761.67 | 638.94 | 624.14 | 154.40 | 162.48 | 42.92 |
Interest Debt per Share |
0.02 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
61,258.00 | 19,495.43 | 9,811.03 | 2,167.30 | 4,761.67 | 638.94 | 624.14 | 154.40 | 162.48 | 42.92 |
Free Cash Flow |
(27.50) | (34.58) | (55.70) | (94.05) | (92.64) | (109.03) | (79.11) | (28.49) | (29.59) | (32.01) |
Working Capital |
40.08 | 100.34 | 160.02 | 80.71 | 149.15 | 86.94 | 60.26 | 44.52 | 35.84 | 7.00 |
Capital Expenditures |
(0.15) | (0.48) | (1.58) | (1.33) | (1.94) | (0.79) | (0.20) | (0.56) | (0.21) | (0.01) |
Net Current Asset Value |
29.93 | 88.35 | 61.04 | (19.15) | 49.77 | 1.74 | 18.10 | 4.43 | 9.65 | 7.00 |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.22 | 0.31 | 0.07 | 0.05 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (1,553.29%) | (1,639.85%) | (1,268.73%) | (1,151.64%) | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.68 | 0.96 | 0.29 | 0.67 | 0.62 | 0.92 | 4.91 | 2.07 | 2.01 | 0.00 |
Cash ROIC |
(32.58%) | (15.65%) | (16.24%) | (50.85%) | (28.68%) | (53.74%) | (56.10%) | (29.66%) | (30.56%) | (219.82%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.97 | 0.60 | 0.90 | 0.50 | — | — | — |
Accounts Payable Turnover |
0.27 | 0.58 | 0.29 | 0.50 | 1.50 | 1.24 | 0.66 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.22 | 0.46 | 0.64 | 0.59 | 0.00 | — | — | — |
Average Days of Payables |
1,225.27 | 682.32 | 2,081.46 | 457.70 | 198.32 | 436.45 | 403.78 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 1,565.10 | 844.88 | 601.51 | 769.64 | 0.00 | — | — | — |
Average Receivables |
— | — | 6.29 | 6.29 | 10.58 | 12.47 | 7.77 | — | — | — |
Average Payables |
1.10 | 1.10 | 3.32 | 3.98 | 2.12 | 3.31 | 3.87 | 1.88 | 0.77 | 0.81 |
Average Inventory |
— | — | 4.37 | 4.37 | 4.94 | 6.93 | — | — | — | — |
Average Assets |
23.16 | 81.44 | 168.76 | 187.64 | 187.96 | 180.52 | 113.12 | 71.38 | 55.72 | 32.49 |
Average Common Equity |
0.96 | 0.96 | 97.33 | 67.34 | 64.84 | 58.40 | 17.89 | 13.24 | 9.92 | 9.66 |
Columns are period end dates